Shares in Cambridge biopharma company Arecor Therapeutics hit a 52-week low at 54.75p on Friday before recovering to close at ...
Arecor Therapeutics announced plans to cease operations within its subsidiary Tetris Pharma during 2025 on Friday, adding ...
Arecor Therapeutics has signed an exclusive licensing agreement for AT351, its ready-to-dilute (RTD) liquid drug product, ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...